These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1363903)

  • 21. [Ventricular arrhythmias and sudden cardiac death].
    Abuladze GV; Nevieridze MI; Abashidze RI; Gabarashvili LV; Kvirkveliia AA
    Georgian Med News; 2009 Mar; (168):50-3. PubMed ID: 19359720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The patient at risk of sudden death:value of drug therapy].
    Bonhorst D
    Rev Port Cardiol; 2000 Feb; 19(2):233-9. PubMed ID: 10763353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of amiodarone.
    Nolan PE; Nappi J; Pollak PT
    Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiac insufficiency: prevention of ventricular arrhythmias].
    Mabo P; Leclercq C; Pavin D
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():23-8. PubMed ID: 10830085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of sudden cardiac death.
    Goldberger JJ
    Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.
    Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How and why treat ventricular hyperkinetic arrhythmias].
    Leclercq JF; Coumel P
    G Ital Cardiol; 1984 Apr; 14(4):273-8. PubMed ID: 6735020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malignant ventricular arrhythmias in the subacute and late phases of myocardial infarction. Clinical arrhythmological characteristics and prognostic value].
    Proclemer A; Facchin D; Fresco C; Bernardi G; Fontanelli A; Feruglio GA
    G Ital Cardiol; 1990 May; 20(5):400-11. PubMed ID: 2210161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current approaches to evaluation and management of patients with ventricular arrhythmias.
    Buxton AE; Kirk MM; Michaud GF
    Med Health R I; 2001 Feb; 84(2):58-62. PubMed ID: 11272662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.
    Fischer A; Verma R; Gomes JA; Mehta D
    Mt Sinai J Med; 2002 Sep; 69(4):197-207. PubMed ID: 12357261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of beta-adrenergic blocking agents in preventing sudden cardiac death.
    Pitt B
    Circulation; 1992 Jan; 85(1 Suppl):I107-11. PubMed ID: 1345815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.